FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Kronos Bio's Free Cash Flow for the
three
months ended in Dec. 2024 was $-12.84 Mil. Kronos Bio's Revenue for the
three
months ended in Dec. 2024 was $2.27 Mil. Therefore, Kronos Bio's FCF Margin % for the quarter that ended in Dec. 2024 was -565.42%.
The historical rank and industry rank for Kronos Bio's FCF Margin % or its related term are showing as below:
KRON'
s FCF Margin % Range Over the Past 10 Years
Min: -1260.51 Med: -962.5 Max: -664.49
Current: -664.52
During the past 7 years, the highest FCF Margin % of Kronos Bio was -664.49%. The lowest was -1260.51%. And the median was -962.50%.
KRON's FCF Margin % is ranked worse than 73.08% of 1018
companies
in the Biotechnology industry
Industry Median: -139.165
vs KRON: -664.52
Kronos Bio FCF Margin % Historical Data
The historical data trend for Kronos Bio's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Kronos Bio's FCF Margin %
For the Biotechnology subindustry, Kronos Bio's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kronos Bio's FCF Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kronos Bio's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Kronos Bio's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kronos Bio FCF Margin % Related Terms
Thank you for viewing the detailed overview of Kronos Bio's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
KRON has been successfully added to your 